Skip to main navigation Skip to search Skip to main content

A phase i study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

  • Manik Amin
  • , Susan E. Minton
  • , Patricia M. Lorusso
  • , Smitha S. Krishnamurthi
  • , Cheryl A. Pickett
  • , Jared Lunceford
  • , Darcy Hille
  • , David Mauro
  • , Mark N. Stein
  • , Andrea Wang-Gillam
  • , Lauren Trull
  • , A. Craig Lockhart

Research output: Contribution to journal › Article › peer-review

38   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase i study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science